In this issue of J Neurol Sci, Cappellari and colleagues [
[1]
] reported very important information that statin treatment beginning before stroke
and continued during the acute phase was associated with symptomatic intracerebral
hemorrhage and statin treatment beginning within 24 h after IV thrombolysis may improve short- and long-term outcome. Although the data
were analyzed by statistical methods, the data should be interpreted with caution.To read this article in full you will need to make a payment
Purchase one-time access:
Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online accessOne-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribe:
Subscribe to Journal of the Neurological SciencesAlready a print subscriber? Claim online access
Already an online subscriber? Sign in
Register: Create an account
Institutional Access: Sign in to ScienceDirect
References
- Does statin in the acute phase of ischemic stroke improve outcome after intravenous thrombolysis? A retrospective study.J Neurol Sci. 2011; 308 (15): 128-134
- Statins in stroke prevention and carotid atherosclerosis: systematic review and up-to-date meta-analysis.Stroke. 2004; 35: 2902-2909
- Lipid management in the prevention of stroke:review and updated meta-analysis of statins for stroke prevention.Lancet Neurol. 2009; 8: 453-463
- Atorvastatin reduces the risk of cardiovascular events in patients with carotid atherosclerosis: a secondary analysis of the Stroke Prevention by Aggressive Reduction in Cholesterol Levels (SPARCL) trial.Stroke. 2008; 39: 3297-3302
- Clinicoradiological Profile and Serum Lipid Levels of Intracerebral Hemorrhage in Prior Statin Users.Intern Med. 2011; 50: 1385-1391
Article info
Publication history
Published online: October 20, 2011
Received:
September 12,
2011
Identification
Copyright
© 2011 Elsevier B.V. Published by Elsevier Inc. All rights reserved.
